Home / 제품소개 / 상세페이지





ADAM™ MC2를 사용한 논문 자료
|
Title |
|
Hybrid SMART spheroids to enhance stem cell therapy for CNS injuries. Science advances, 2021 Link: https://doi.org/10.1126/sciadv.abj2281 |
| Plasma complement C7 as a target in non-small cell lung cancer patients to implement 3P medicine strategies. EPMA Journal, 2021 Link: https://doi.org/10.1007/s13167-021-00266-x |
|
Adoptive immunotherapy with transient anti-CD4 treatment enhances anti-tumor response by increasing IL-18Rαhi CD8+ T cell, Nature Communications, 2021 Link: https://doi.org/10.1038/s41467-021-25559-7 |
| IL7-Fc Enhances the Efficacy of Adoptive T Cell Therapy under Lymphopenic Conditions in a Murine Melanoma Model, Cells, 2021 Link: https://doi.org/10.3390/cells10082018 |
| TDP-43 and PINK1 mediate CHCHD10 S59L mutation–induced defects in Drosophila and in vitro. Nature Communications, 2021 Link: https://doi.org/10.1038/s41467-021-22145-9 |
|
Polymorphic Region-Specific Antibody for Evaluation of Affinity-Associated Profile of Chimeric Antigen Receptor, Molecular Therapy Oncolytics, 2020 Link: https://www.sciencedirect.com/science/article/pii/S2372770520300541 |
|
Chronic activation of 4-1BB signaling induces granuloma development in tumor-draining lymph nodes that is detrimental to subsequent CD8+ T cell responses, Cellular & Molecular Immunology, 2020 Link: https://doi.org/10.1038/s41423-020-00533-3 |
| Differential physical interactions of wild-type and S59L mutant CHCHD10 with mitochondrial proteases, F1000Research, 2024 Link: https://doi.org/10.12688/f1000research.151962.1 |
| FDA-approved PDE4 inhibitors alleviate the dominant toxicity of ALS–FTD-associated CHCHD10S59L by reducing the PINK1/Parkin pathway, Research Square, 2024 Link: https://doi.org/10.21203/rs.3.rs-4870330/v1 |
제품명 / Cat. No.
ADAM–MC2 / ADAM–MC2
샘플 주입량
13 µL/test (4 ch)
샘플 측정량
3.4 µL/test (4ch)
측정 범위
5 X 10E4–4 X 10E6 cells/mL(PI)
5 X 10E4–2 X 10E7 cells/mL (AO/PI)
포커스
자동 포커스 기능
LED
4W Green LED
무게
7.0 kg
크기 (LxWxH)
277 x 276 x 270 mm
분석 시간
< 25 sec/test (4 ch)
ExTransfection™은 사용자가 손쉽게 실험을 설정하고 수행할 수 있도록 오픈 프로토콜을 제공합니다. 24-well 최적화 방식을 통해 transfection 프로토콜을 빠르고 간단하게 최적화할 수 있습니다.
또한 adherent과 suspended cells 모두에 대해 전기적 매개변수를 효율적이고 신속하게 최적화할 수 있는 사전 프로그래밍 된 최적화 프로토콜이 포함되어 있습니다.
